Published in Cancer Res Treat on April 30, 2005
Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients. Pediatr Blood Cancer (2015) 2.88
Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patients. Cancer (2012) 0.99
Glucarpidase to combat toxic levels of methotrexate in patients. Ther Clin Risk Manag (2012) 0.93
Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer (1982) 3.82
High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma. Cancer (2004) 1.65
Molecular cloning of the Pseudomonas carboxypeptidase G2 gene and its expression in Escherichia coli and Pseudomonas putida. J Bacteriol (1983) 1.54
Methotrexate: clinical pharmacology, current status and therapeutic guidelines. Cancer Treat Rev (1977) 1.46
Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction. J Clin Oncol (1997) 1.18
Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid. J Pharmacol Exp Ther (2000) 1.06
The role of 7-hydroxymethotrexate during methotrexate anti-cancer therapy. Cancer Lett (1980) 0.99
Removal of methotrexate, leucovorin, and their metabolites by combined hemodialysis and hemoperfusion. Cancer (1988) 0.94
High-dose leucovorin as sole therapy for methotrexate toxicity. J Clin Oncol (1999) 0.94
Removal of methotrexate by continuous venovenous hemodiafiltration. Contrib Nephrol (1995) 0.88
Continuous plasma resin perfusion for detoxification of methotrexate. Eur J Pediatr (1997) 0.85
A case of methotrexate-induced acute renal failure successfully treated with plasma perfusion and sequential hemodialysis. Nephron (1995) 0.85
Genome-wide association study of childhood acute lymphoblastic leukemia in Korea. Leuk Res (2010) 1.85
The enigma of bifocal germ cell tumors in the suprasellar and pineal regions: synchronous lesions or metastasis? J Neurosurg Pediatr (2012) 1.75
Pharmacogenetic analysis of pediatric patients with acute lymphoblastic leukemia: a possible association between survival rate and ITPA polymorphism. PLoS One (2012) 1.60
Generation of PLZF+ CD4+ T cells via MHC class II-dependent thymocyte-thymocyte interaction is a physiological process in humans. J Exp Med (2009) 1.44
Long-term outcomes in children with glioblastoma. J Neurosurg Pediatr (2010) 1.39
Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study. Stroke (2009) 1.20
Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study. Haematologica (2010) 1.16
Current status of pediatric umbilical cord blood transplantation in Korea: a multicenter retrospective analysis of 236 cases. Am J Hematol (2011) 1.15
Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy. J Antimicrob Chemother (2007) 1.13
Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk. Leuk Res (2008) 1.13
Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood (2006) 1.10
Mesenchymal stem cells transfer mitochondria to the cells with virtually no mitochondrial function but not with pathogenic mtDNA mutations. PLoS One (2012) 1.08
UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis. Haematologica (2009) 1.07
Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study. Biol Blood Marrow Transplant (2010) 1.07
Pre-engraftment syndrome after unrelated cord blood transplantation: a predictor of engraftment and acute graft-versus-host disease. Biol Blood Marrow Transplant (2013) 1.07
Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer. Gynecol Oncol (2010) 1.06
Reduced-dose craniospinal radiotherapy followed by high-dose chemotherapy and autologous stem cell rescue for children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuroectodermal tumor. Korean J Hematol (2010) 1.00
Hereditary hemolytic anemia in Korea from 2007 to 2011: A study by the Korean Hereditary Hemolytic Anemia Working Party of the Korean Society of Hematology. Blood Res (2013) 0.99
Intracranial growing teratoma syndrome: clinical characteristics and treatment strategy. J Neurooncol (2010) 0.97
Cross-cultural adaptation of the korean version of the minneapolis-manchester quality of life instrument-adolescent form. J Korean Med Sci (2013) 0.95
Successful treatment of primary central nervous system lymphoma without irradiation in children: single center experience. J Korean Med Sci (2012) 0.93
Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome. Pediatr Nephrol (2011) 0.93
Renal manifestations of patients with MYH9-related disorders. Pediatr Nephrol (2011) 0.93
Founder effects in two predominant intronic mutations of UNC13D, c.118-308C>T and c.754-1G>C underlie the unusual predominance of type 3 familial hemophagocytic lymphohistiocytosis (FHL3) in Korea. Ann Hematol (2012) 0.93
Acute leukemia: an association with atypical hemolytic uremic syndrome. Pediatr Nephrol (2003) 0.92
Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trial. Mol Ther (2011) 0.91
The outcome of hematopoietic stem cell transplantation in Korean children with hemophagocytic lymphohistiocytosis. Pediatr Transplant (2010) 0.90
Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease. Mov Disord (2008) 0.89
Nephrotic syndrome in a child after umbilical-cord-blood transplantation. Pediatr Nephrol (2006) 0.89
Contributing factors analysis for the changes of the gross motor function in children with spastic cerebral palsy after physical therapy. Ann Rehabil Med (2013) 0.88
Cerebrospinal fluid M staging for medulloblastoma: reappraisal of Chang's M staging based on the CSF flow. Neuro Oncol (2010) 0.88
Unrelated donor cord blood transplantation for non-malignant disorders in children and adolescents. Pediatr Transplant (2013) 0.88
Genetic variants in interleukin-2 and risk of lymphoma among children in Korea. Asian Pac J Cancer Prev (2012) 0.88
Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells. J Pathol (2004) 0.88
Clinical result of prolonged primary chemotherapy in retinoblastoma patients. Korean J Ophthalmol (2003) 0.88
Pediatric infratentorial ependymoma: prognostic significance of anaplastic histology. J Neurooncol (2011) 0.87
Double umbilical cord blood transplantation for children and adolescents. Ann Hematol (2010) 0.86
High transcript level of FLT3 associated with high risk of relapse in pediatric acute myeloid leukemia. J Korean Med Sci (2010) 0.86
Efficacy of high-dose chemotherapy and autologous stem cell transplantation in patients with relapsed medulloblastoma: a report on the Korean Society for Pediatric Neuro-Oncology (KSPNO)-S-053 study. J Korean Med Sci (2010) 0.86
Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients. Hum Immunol (2010) 0.86
Prognostic significance of FLT3 mutations in pediatric non-promyelocytic acute myeloid leukemia. Leuk Res (2005) 0.86
CNS recurrence following CD34+ peripheral blood stem cell transplantation in stage 4 neuroblastoma. Pediatr Blood Cancer (2005) 0.85
Highly variable pharmacokinetics of once-daily intravenous busulfan when combined with fludarabine in pediatric patients: phase I clinical study for determination of optimal once-daily busulfan dose using pharmacokinetic modeling. Biol Blood Marrow Transplant (2011) 0.85
The use of standardized patients to teach medical students clinical skills in ambulatory care settings. Med Teach (2010) 0.85
PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia. Blood Cells Mol Dis (2011) 0.84
Epidemiology and clinical long-term outcome of childhood aplastic anemia in Korea for 15 years: retrospective study of the Korean Society of Pediatric Hematology Oncology (KSPHO). J Pediatr Hematol Oncol (2011) 0.84
Arsenic trioxide concentration determines the fate of Ewing's sarcoma family tumors and neuroblastoma cells in vitro. FEBS Lett (2006) 0.84
Atypical teratoid/rhabdoid tumors: the need for more active therapeutic measures in younger patients. J Neurooncol (2011) 0.84
Novel regimen for the treatment of juvenile myelomonocytic leukemia (JMML). Leuk Res (2004) 0.84
Clinical characteristics and treatment results of pediatric osteosarcoma: the role of high dose chemotherapy with autologous stem cell transplantation. Cancer Res Treat (2008) 0.83
Factors affecting retrovirus-mediated gene transfer to human CD34+ cells. J Gene Med (2004) 0.83
Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party. Eur J Haematol (2014) 0.83
In vitro generation of functional dendritic cells from human umbilical cord blood CD34+ cells by a 2-step culture method. Int J Hematol (2004) 0.83
Therapeutic effect of repetitive transcranial magnetic stimulation in Parkinson's disease: analysis of [11C] raclopride PET study. Mov Disord (2008) 0.83
Cytomegalovirus infection in seropositive unrelated cord blood recipients: a study of 349 Korean patients. Ann Hematol (2014) 0.82
Retrospective analysis of peripheral blood stem cell transplantation for the treatment of high-risk neuroblastoma. J Korean Med Sci (2007) 0.82
Incidence of submicroscopic deletions vary according to disease entities and chromosomal translocations in hematologic malignancies: investigation by fluorescence in situ hybridization. Cancer Genet Cytogenet (2007) 0.82
Loss of heterozygosity analysis of chromosome 17p13.1-13.3 and its correlation with clinical outcome in medulloblastomas. J Neurooncol (2004) 0.82
Clinical course of non-severe aplastic anemia in adults. Int J Hematol (2010) 0.82